Equities

Fortis Healthcare Ltd

FORTIS:NSI

Fortis Healthcare Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)683.35
  • Today's Change1.40 / 0.21%
  • Shares traded3.14m
  • 1 Year change+87.12%
  • Beta0.8044
Data delayed at least 15 minutes, as of Nov 22 2024 09:45 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Fortis Healthcare Ltd had little change in net income (from 5.89bn to 5.99bn) despite revenues that grew 9.45% from 62.98bn to 68.93bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 26.67% to 26.81%.
Gross margin76.46%
Net profit margin9.63%
Operating margin14.06%
Return on assets5.34%
Return on equity8.49%
Return on investment7.68%
More ▼

Cash flow in INRView more

In 2024, Fortis Healthcare Ltd increased its cash reserves by 275.82%, or 1.25bn. The company earned 11.00bn from its operations for a Cash Flow Margin of 15.96%. In addition the company used 8.86bn on investing activities and also paid 864.58m in financing cash flows.
Cash flow per share14.16
Price/Cash flow per share48.05
Book value per share103.94
Tangible book value per share43.09
More ▼

Balance sheet in INRView more

Fortis Healthcare Ltd has a Debt to Total Capital ratio of 11.97%, a higher figure than the previous year's 10.81%.
Current ratio0.4708
Quick ratio0.4369
Total debt/total equity0.1512
Total debt/total capital0.1197
More ▼

Growth rates in INR

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 1.72%.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)11.43%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
19.61
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.